Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1991 1
1992 1
1993 3
1994 3
1995 6
1996 7
1997 2
1998 1
1999 4
2000 9
2001 4
2002 6
2003 9
2004 2
2005 6
2006 5
2007 7
2008 8
2009 7
2010 6
2011 3
2012 5
2013 10
2014 8
2015 7
2016 9
2017 3
2018 8
2019 8
2020 3
2021 6
2022 10
2023 2
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

163 results

Results by year

Filters applied: . Clear all
Page 1
BRCAness in prostate cancer.
Bednarz-Knoll N, Eltze E, Semjonow A, Brandt B. Bednarz-Knoll N, et al. Among authors: semjonow a. Oncotarget. 2019 Mar 29;10(25):2421-2422. doi: 10.18632/oncotarget.26818. eCollection 2019 Mar 29. Oncotarget. 2019. PMID: 31069005 Free PMC article. No abstract available.
A Multivariable Approach Using Magnetic Resonance Imaging to Avoid a Protocol-based Prostate Biopsy in Men on Active Surveillance for Prostate Cancer-Data from the International Multicenter Prospective PRIAS Study.
Luiting HB, Remmers S, Boevé ER, Valdagni R, Chiu PK, Semjonow A, Berge V, Tully KH, Rannikko AS, Staerman F, Roobol MJ. Luiting HB, et al. Among authors: semjonow a. Eur Urol Oncol. 2022 Dec;5(6):651-658. doi: 10.1016/j.euo.2022.03.007. Epub 2022 Apr 15. Eur Urol Oncol. 2022. PMID: 35437217 Free article.
Proposal for a standardized PSA doubling-time calculation.
Ponholzer A, Popper N, Breitenecker F, Schmid HP, Albrecht W, Loidl W, Madersbacher S, Schramek P, Semjonow A, Rauchenwald M. Ponholzer A, et al. Among authors: semjonow a. Anticancer Res. 2010 May;30(5):1633-6. Anticancer Res. 2010. PMID: 20592353
PROPOSe: A Real-life Prospective Study of Proclarix, a Novel Blood-based Test to Support Challenging Biopsy Decision-making in Prostate Cancer.
Steuber T, Heidegger I, Kafka M, Roeder MA, Chun F, Preisser F, Palisaar RJ, Hanske J, Budaeus L, Schiess R, Keller T, Semjonow A, Hammerer P, Manka L, Ecke T, Schwentner C, Ohlmann C. Steuber T, et al. Among authors: semjonow a. Eur Urol Oncol. 2022 Jun;5(3):321-327. doi: 10.1016/j.euo.2020.12.003. Epub 2021 Jan 6. Eur Urol Oncol. 2022. PMID: 33422560
EGFR as a stable marker of prostate cancer dissemination to bones.
Nastały P, Stoupiec S, Popęda M, Smentoch J, Schlomm T, Morrissey C, Żaczek AJ, Beyer B, Tennstedt P, Graefen M, Eltze E, Maiuri P, Semjonow A, Pantel K, Brandt B, Bednarz-Knoll N. Nastały P, et al. Among authors: semjonow a. Br J Cancer. 2020 Dec;123(12):1767-1774. doi: 10.1038/s41416-020-01052-8. Epub 2020 Sep 9. Br J Cancer. 2020. PMID: 32901137 Free PMC article.
Active surveillance for low-risk prostate cancer.
Bangma CH, Bul M, van der Kwast TH, Pickles T, Korfage IJ, Hoeks CM, Steyerberg EW, Jenster G, Kattan MW, Bellardita L, Carroll PR, Denis LJ, Parker C, Roobol MJ, Emberton M, Klotz LH, Rannikko A, Kakehi Y, Lane JA, Schröder FH, Semjonow A, Trock BJ, Valdagni R. Bangma CH, et al. Among authors: semjonow a. Crit Rev Oncol Hematol. 2013 Mar;85(3):295-302. doi: 10.1016/j.critrevonc.2012.07.005. Epub 2012 Aug 9. Crit Rev Oncol Hematol. 2013. PMID: 22878262 Review.
Prospective randomized evaluation of risk-adapted prostate-specific antigen screening in young men: the PROBASE trial.
Arsov C, Becker N, Hadaschik BA, Hohenfellner M, Herkommer K, Gschwend JE, Imkamp F, Kuczyk MA, Antoch G, Kristiansen G, Siener R, Semjonow A, Hamdy FC, Lilja H, Vickers AJ, Schröder FH, Albers P. Arsov C, et al. Among authors: semjonow a. Eur Urol. 2013 Dec;64(6):873-5. doi: 10.1016/j.eururo.2013.05.022. Epub 2013 May 14. Eur Urol. 2013. PMID: 23707067 Clinical Trial. No abstract available.
Decision aid and cost compensation influence uptake of PSA-based early detection without affecting decisional conflict: a cluster randomised trial.
Tiedje D, Borowski M, Simbrich A, Schlößler K, Kruse K, Bothe C, Kuss K, Adarkwah CC, Maisel P, Jendyk R, Kurosinski MA, Gerß J, Tschuschke C, Becker R, Roobol MJ, Bangma CH, Hense HW, Donner-Banzhoff N, Semjonow A. Tiedje D, et al. Among authors: semjonow a. Sci Rep. 2021 Dec 6;11(1):23503. doi: 10.1038/s41598-021-02696-z. Sci Rep. 2021. PMID: 34873188 Free PMC article. Clinical Trial.
163 results